Free Trial
NYSEARCA:CURE

Direxion Daily Healthcare Bull 3x Shares (CURE) Price, Holdings, & News

$80.67 +1.54 (+1.95%)
As of 08/29/2025 04:10 PM Eastern

About Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE)

Key Stats

Today's Range
$79.17
$80.74
50-Day Range
$67.57
$82.23
52-Week Range
$66.00
$143.51
Volume
204,313 shs
Average Volume
103,311 shs
Market Capitalization
$157.31 million
Assets Under Management
$165.47 million
Dividend Yield
1.36%
Net Expense Ratio
0.93%
Aggregate Rating
Moderate Buy

ETF Overview

Direxion Daily Healthcare Bull 3x Shares Expenses

TypeCUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.51%0.53%
Other Expenses0.18%0.47%0.56%0.59%0.56%
Total Expense0.93%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.93%0.60%0.63%0.58%0.60%
Receive CURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily Healthcare Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CURE ETF News Headlines

CURE: Adding Defensive Exposure Amid Frothy Market Valuations
Turn $1K into $50K with This DeFi Gem
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.tc pixel
CURE: A Leveraged ETF To Own Throughout This Century
See More Headlines

CURE ETF - Frequently Asked Questions

Direxion Daily Healthcare Bull 3x Shares' stock was trading at $92.29 at the start of the year. Since then, CURE shares have decreased by 12.6% and is now trading at $80.67.

Top institutional investors of Direxion Daily Healthcare Bull 3x Shares include SBI Securities Co. Ltd. (0.38%), Rovin Capital UT ADV (0.14%), Tower Research Capital LLC TRC (0.13%) and Jane Street Group LLC.
View institutional ownership trends
.

Shares of CURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily Healthcare Bull 3x Shares investors own include ProShares UltraPro QQQ (TQQQ), Tesla (TSLA), NVIDIA (NVDA), Costco Wholesale (COST), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Direxion Daily Financial Bull 3X Shares (FAS) and Direxion Daily Gold Miners Index Bull 2x Shares (NUGT).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily Healthcare Bull 3x Shares
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:CURE
Inception Date
6/15/2011
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Health Care Select Sector Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
70

Fund Statistics

Assets Under Management
$165.47 million
Average Daily Volume
$236.51 thousand
Discount/Premium
-0.05%
Leveraged
3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
244
Put Options
59
Call Options
185
Short Interest
121,200 shs

Miscellaneous

Beta
2.20
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Top 10 CURE Holdings

CURE Sector Exposure

CURE Industry Exposure


This page (NYSEARCA:CURE) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners